MORROW GEORGE J
SEC Form 4 insider trading activity
MORROW GEORGE J has filed 4 SEC Form 4 filings (19 transaction rows) across 2 companies, including NBIX, ALGN, with disclosures dating back to 2025. 4 of those filings fall inside the rolling window. Most recent filing: Nov 3, 2026.
On the most recent filing, MORROW GEORGE J is listed as Director at NEUROCRINE BIOSCIENCES INC. Inside the rolling window, MORROW GEORGE J reported no open-market purchases and 4 open-market sales totaling $4.5M in NBIX. The largest disclosed transaction in the window is a sale of 15,000 NBIX shares on Nov 25, 2025, worth $2.2M.
Companies traded
Other insiders at NBIX
Insider Buying
$0
reported purchases (SEC code P)
Insider Selling
$4.5M
reported sales (SEC code S)
Companies
2
in the rolling window
Frequently asked questions
How many SEC Form 4 filings has MORROW GEORGE J made?
MORROW GEORGE J has filed 4 SEC Form 4 filings (19 transaction rows) across 2 companies, including NBIX, ALGN since 2025.
Which companies does MORROW GEORGE J trade?
MORROW GEORGE J has filed SEC Form 4 disclosures for 2 companies, including NBIX, ALGN.
When was MORROW GEORGE J's most recent SEC Form 4 filing?
MORROW GEORGE J's most recent SEC Form 4 filing on Tracefour is dated Nov 3, 2026.
What is MORROW GEORGE J's total buy and sell value in the current window?
Inside the rolling retention window, MORROW GEORGE J bought $0 and sold $4.5M based on SEC Form 4 filings.
What was MORROW GEORGE J's largest disclosed transaction?
The largest disclosed transaction in the current window is a sale of 15,000 NBIX shares on 2025-11-25, worth $2.2M, per SEC Form 4 filings.